Opinion/decision on a Paediatric investigation plan (PIP): Lenvima, Lenvatinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0280/2022

Opinion/decision on a Paediatric investigation plan (PIP): Upstaza, Eladocagene exuparvovec, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0075/2023

Opinion/decision on a Paediatric investigation plan (PIP): Aflunov, Influenza virus surface antigens - A/turkey/Turkey/1/05 (H5N1), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Vaccines, PIP number: P/0189/2020

EMEA-002475-PIP02-19-M02

EMEA-003330-PIP01-22

Opinion/decision on a Paediatric investigation plan (PIP): Palforzia, defatted powder of Arachis hypogaea L., semen (peanuts), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0103/2023

Opinion/decision on a Paediatric investigation plan (PIP): Aubagio, Teriflunomide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0165/2017

Opinion/decision on a Paediatric investigation plan (PIP): Vimizim, Recombinant human N-acetylgalactosamine-6-sulfatase (elosulfase alfa), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism, PIP number: P/0170/2023

EMEA-000637-PIP02-10-M07

Opinion/decision on a Paediatric investigation plan (PIP): Edurant, Rilpivirine (hydrochloride), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0101/2022